期刊
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE
卷 36, 期 1, 页码 145-151出版社
AMER BOARD FAMILY MEDICINE
DOI: 10.3122/jabfm.2022.220239R1
关键词
Antidepressants; Anxiety Disorders; Bipolar Disorder; Depression; Drug Tapering; Mental Health; Primary Health Care; Psychiatry
When discontinuing antidepressants, it is important to carefully taper the dose in order to minimize withdrawal symptoms. However, it is difficult to determine which patients will struggle without a taper. A one-size-fits-all taper approach is recommended.
Introduction: When antidepressants are discontinued, severe withdrawal symptoms are possible. Some patients have few or no problems stopping, whereas others struggle. That struggle can be minimized or prevented with careful dose tapering. How often is that done? Methods: Using 7 years of medical records, we determined the percentage of patients who received a prescription for the lowest available dose of their antidepressant before it was discontinued, as an indicator of a deliberate taper. Results: Over that period, 8.9% of patients had evidence of tapering. The percentage increased from 4.9% in 2014 to a plateau around 10% in the past 4 years. Discussion: While reports of severe withdrawal are increasingly recognized and must be addressed, our data suggest that many patients can discontinue their antidepressants without a taper through the lowest dose. However, it is difficult to identify which patients will struggle without a careful taper. A one-size-fits-all taper approach is recommended, balancing the need for withdrawal prevention with the need to avoid unnecessary complexity for the majority of patients. The first decrement is key for all patients: it must go well. Thereafter many patients may accelerate but all should receive a prescription for the lowest available dose of their antidepressant.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据